Results 161 to 170 of about 10,122 (213)

Microangiopathic Hemolytic Anemia Following Transjugular Intrahepatic Portosystemic Shunt Creation in an Adolescent. [PDF]

ACG Case Rep J
Khoo JY, Lessne ML, Gopalareddy VV.
europepmc   +1 more source

Lines of Zahn in a Patient With Transjugular Intrahepatic Portosystemic Shunt Occlusion From a Tumor Thrombus: A Case Report. [PDF]

Cureus
King SJ, Nguyen C, Brownlee MB, Kalman R.   +3 more
europepmc   +1 more source

Efficacy and safety of transjugular intrahepatic portosystemic shunt in hepatic sinusoidal obstruction syndrome: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Jiang X, Ma X, Tian S, Peng L.
europepmc   +1 more source

Association between preoperative platelet count and transjugular intrahepatic portosystemic shunt procedure-related hemorrhage in cirrhotic patients: a retrospective study. [PDF]

Front Med (Lausanne)
Li Y, Xu J, Quan X, Wei B, Tai Y, Wu H.
europepmc   +1 more source

The transjugular intrahepatic portosystemic shunt (TIPS)

Clinical Radiology, 2009
The creation of an intrahepatic portosystemic shunt via a transjugular approach (TIPS) is an interventional radiological procedure used to treat the complications of portal hypertension. TIPS insertion is principally indicated to prevent or arrest variceal bleeding when medical or endoscopic treatments fail, and in the management refractory ascites ...
A R, Owen, A J, Stanley, A, Vijayananthan, J G, Moss   +3 more
openaire   +3 more sources

The History of the Transjugular Intrahepatic Portosystemic Shunt

Seminars in Interventional Radiology, 2023
AbstractFew, if any, developments in the past three decades have advanced the field of portal hypertension more than the use of transjugular intrahepatic portosystemic shunts (TIPS). Initially pursued in animal studies more than 50 years ago, and discovered serendipitously, TIPS quickly became used clinically in the treatment of refractory esophageal ...
Hector, Ferral, Ruben, Lopez-Benitez
openaire   +3 more sources

Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications

United European Gastroenterology Journal, 2020
BACKGROUND Treatment of refractory ascites in liver cirrhosis is challenging. Transjugular intrahepatic portosystemic shunt and alfapump® have been proposed for the management, but few data comparing both exist. AIMS The aim of this study was to
Valerie Will, Susana G Rodrigues, Guido Stirnimann   +2 more
exaly   +2 more sources

Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome

Clinics and Research in Hepatology and Gastroenterology, 2022
Transjugular intrahepatic portosystemic shunt (TIPS) is nowadays the benchmark treatment of severe portal hypertension complications. However, besides usual contraindication to the procedure (namely recurrent hepatic encephalopathy, severe liver ...
Florent Artru, Eleni Moschouri, Alban Denys   +2 more
exaly   +2 more sources

Transjugular Intrahepatic Portosystemic Shunts

Clinics in Liver Disease, 2020
Cirrhosis and its complications are common throughout the world. Hepatitis B and C and alcohol abuse account for about 90% of cases. There is significant morbidity associated with ascites, portal hypertension, and variceal bleeding.
Mark Duncan Brooks, Julian Maingard
core   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Transjugular Intrahepatic Portosystemic Shunt

Contemporary Diagnostic Radiology, 2022
Chronic liver disease is the 11th leading cause of mortality in the United States.1 Portal hypertension is a common endpoint for progressive liver disease, and can clinically manifest as refractory ascites, splenomegaly, and life-threatening esophageal and gastric variceal bleeding.
Michelle T. Martin, Wadih Chacra
  +4 more sources